Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Celsius Holdings reports Q1 results on May 28 with short sellers adding pressure and the Street trimming expectations — yet options traders remain notably calm.
Short interest is the most charged signal heading into the print. At 9.5% of free float, it has climbed roughly 8% over the past month, with the majority of that build concentrated in the past two weeks as shares crossed from the mid-$30s to below $30. The ORTEX short score runs at 62.8, placing Celsius in the bottom decile of its universe on that measure. Despite that positioning, the borrow market is not under stress: cost to borrow is a low 0.50%, and availability is running at 182% — meaning more than enough shares remain in the lending pool to absorb further short demand without a squeeze.
Options positioning tells a quieter story. The put/call ratio is 0.41, slightly below its 20-day average of 0.42 and near the lower end of its 52-week range. That is not the pattern of a market hedging aggressively into a feared print — it reads closer to indifference. The stock itself has lost 14% over the past month to close at $29.67, but recovered about 2% on the week, and sits roughly 37% lower year-to-date. Peers and are broadly flat to slightly positive on the week, making Celsius's prolonged underperformance a company-specific story rather than a sector one.
The analyst debate centres on whether Celsius can prove its growth story still holds. Bulls point to the PepsiCo distribution partnership, the Alani Nu integration, and a forward earnings trajectory that ranks in the 92nd percentile for year-on-year EPS growth. BNP Paribas cut its target to $57 from $70 on May 26 while keeping an Outperform rating — still implying roughly 90% upside from current levels. JP Morgan and Morgan Stanley both trimmed targets earlier this month, but neither abandoned positive ratings. The consensus mean target at $61 reflects a Street that sees value in the brand but is becoming more selective on the near-term execution. Bears flag intensifying competition in the zero-sugar energy segment and execution risk as the Alani Nu transition proceeds, with the concern that near-term revenue momentum could disappoint even as the long-run thesis remains intact.
Earnings history adds context: the last two prints both produced negative five-day reactions of roughly 11-12%, a pattern that short sellers appear to be positioning around again. The May 28 release is therefore less about whether Celsius is a growth brand and more about whether the Alani Nu integration and PepsiCo channel are delivering the tangible volume inflection that would justify owning a stock the market has already marked down by more than a third this year.
See the live data behind this article on ORTEX.
Open CELH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
